Glaxo Smith Kline operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smith Kline with three other
companies in this sector in Egypt:
Egypt International Pharmaceuticals
sales of 1.97 billion Egyptian Pounds [US$110.92 million]
of which 100%
Alexandria Pharmaceuticals and Chemical Industries Co
(424.96 million Egyptian Pounds [US$23.94 million]
Memphis Pharmaceutical & Chemical Industries
(357.80 million Egyptian Pounds [US$20.15 million]
During the year ended December of 2016, sales at
Glaxo Smith Kline were 1.17 billion Egyptian Pounds (US$65.66 million).
increase of 14.2%
versus 2015, when the company's sales were 1.02 billion Egyptian Pounds.
Sales of Consumer Care Sector saw an increase
that was more than double the company's growth rate: sales were up
105.1% in 2016, from
41.86 million Egyptian Pounds to 85.85 million Egyptian Pounds.